Press Releases

Nov 29, 2018 8:07am EST

CollPlant Reports Third Quarter 2018 Financial Results and Provides Business Update

Nov 12, 2018 6:00am EST

CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

Nov 07, 2018 10:00am EST

CollPlant to Ring Nasdaq Opening Bell on November 8, 2018

Oct 28, 2018 8:00am EDT

CollPlant Shares Will Be Traded From Tuesday Oct 30 Exclusively on Nasdaq

Oct 22, 2018 4:00am EDT

CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

Sep 21, 2018 4:10pm EDT

CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug 28, 2018 7:00am EDT

CollPlant Holdings to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

Aug 08, 2018 9:00am EDT

Dual-Listed CollPlant to Voluntarily Delist From Tel Aviv Stock Exchange

Jul 05, 2018 5:55am EDT

CollPlant Appoints Dr. Wolfgang Ruttenstorfer to Its Board of Directors

Jun 26, 2018 5:55am EDT

CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs